isolariciresinol has been researched along with indirubin in 1 studies
| Studies (isolariciresinol) | Trials (isolariciresinol) | Recent Studies (post-2010) (isolariciresinol) | Studies (indirubin) | Trials (indirubin) | Recent Studies (post-2010) (indirubin) |
|---|---|---|---|---|---|
| 36 | 0 | 13 | 347 | 3 | 184 |
| Protein | Taxonomy | isolariciresinol (IC50) | indirubin (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Sus scrofa (pig) | 1 | |
| [Tau protein] kinase | Sus scrofa (pig) | 1 | |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 8.25 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2 | |
| Insulin receptor | Homo sapiens (human) | 2 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 7.74 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 8.8333 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 1 | |
| Cyclin-A2 | Homo sapiens (human) | 3.525 | |
| Cyclin-dependent kinase 11B | Homo sapiens (human) | 2.2 | |
| Kit ligand | Homo sapiens (human) | 2 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 4.85 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 3.24 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 2 | |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | 2.2 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 1.5 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.8515 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 6.15 | |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 6.7143 | |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 20 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 8.25 | |
| Cyclin-dependent kinase 15 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 1 | |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ping, F; Shen, X; Tan, C; Wang, Y; Xing, W; Xu, J; Zhu, L | 1 |
1 other study(ies) available for isolariciresinol and indirubin
| Article | Year |
|---|---|
Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection.
Topics: Alkaloids; Caspase 3; Coronavirus; Coronavirus Infections; COVID-19 Drug Treatment; Cyclooxygenase 2; Databases, Pharmaceutical; Drugs, Chinese Herbal; Flavanones; Humans; Indoles; Interleukin-6; Lignin; Luteolin; Mitogen-Activated Protein Kinase 14; Mitogen-Activated Protein Kinase 8; Molecular Docking Simulation; Naphthols; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type III; Protein Interaction Maps; Quercetin; SARS-CoV-2; Signal Transduction; Sitosterols; Transcriptome | 2022 |